ADIAL PHARMACEUTICALS, INC. - 8-K Filing
Adial Pharmaceuticals adjourned its annual meeting again to October 15 for Proposals 3-6 due to pending Nasdaq approval. (Items: 8.01 Other Events As previously disclosed in that Current Report on Form 8-K filed by Adial Pharmaceuticals, Inc)
Tickers: $ADIL